|Articles|May 1, 2020
- Pharmaceutical Executive-05-01-2020
- Volume 40
- Issue 5
Pharmaceutical Executive, May 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Pharm Exec's Emerging Pharma Leaders 2020about 6 years ago
AI: Kickstarting the Race Against COVID-19about 6 years ago
Competition for Biotech CFOs is Heating Upabout 6 years ago
Biopharma Sustainability Considered Essentialabout 6 years ago
CFOs Outlook: Forging a Sustainable Futureabout 6 years ago
Drive for COVID-19 Therapies Raises Patent and Pricing Issuesover 6 years ago
Biotech in the Age of COVID: The Pain and the Gainover 6 years ago
A New, Less Friendly Normal Looms for European Drugmakersover 6 years ago
How Prepared Were Doctors for the COVID Digital Upswing?over 6 years ago
Pharmaceutical Executive, May 2020 Issue (PDF)Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Modern Policy Concerns Stemming from 340B
2
Funding Roundup: Silence Therapeutics, AbCellera Announce IPO Pricing, Beyang, Remepy Close Series A Financing
3
2026 Emerging Pharma Leaders
4
Pharmaceutical Executive Daily: 2026 Emerging Pharma Leaders Award Winners Announced
5